Enlight (ENLT) executive exercises 35,286 options and sells 26,622 shares
Rhea-AI Filing Summary
Enlight Renewable Energy executive Ilan Goren reported a mix of option exercises, tax withholding and share sales. He exercised 35,286 stock options at $23.22 per share, receiving ordinary shares. The company retained 8,664 shares to cover the option exercise price and related obligations. Goren then sold 26,622 ordinary shares in an open-market transaction at $103.76 per share. After these transactions, he holds 42,835 ordinary shares directly and maintains stock options over 98,743 shares at a $27.33 exercise price expiring on July 29, 2032, and 100,000 shares at a $22.17 exercise price expiring on June 28, 2029. Additional option and RSU positions are included for informational purposes without new transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (right to buy) | 35,286 | $0.00 | $0.00 |
| Exercise | Ordinary shares, NIS 0.1 par value per share | 35,286 | $23.22 | $819K |
| Exercise Price or Tax Liability | Ordinary shares, NIS 0.1 par value per share | 8,664 | $103.76 | $899K |
| Sale | Ordinary shares, NIS 0.1 par value per share | 26,622 | $103.76 | $2.76M |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
Footnotes (10)
- F1. Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
- F2. Includes (i) 14,083 restricted share units granted on April 21, 2024, with 7,041 vesting on April 21, 2027 and 7,042 vesting on April 21, 2028; and (ii) 21,710 restricted share units granted on July 29, 2025, with 5,427 vesting on each of October 1, 2026 and October 1, 2028, and 5,428 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
- F3. These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
- F4. Represents a transaction price of NIS 296.66, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
- F5. Stock options were granted on September 30, 2021, with 35,000 having vested on September 30, 2024; and 30,000 having vested on September 30, 2025.
- F6. Represents an exercise price of NIS 68.64, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
- F7. Stock options were granted on June 28, 2022, with 25,000 having vested on each of June 28, 2023 and June 28, 2024; 35,000 having vested on June 28, 2025; and 15,000 vesting on June 28, 2026.
- F8. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- F9. Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
- F10. Stock options were granted on July 29, 2025, with 24,685 vesting on October 1, 2026; and 24,686 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.
Key Figures
Key Terms
Stock Options (right to buy) financial
tax-withholding disposition financial
Bank of Israel representative exchange rate financial
exercise price financial
AI-generated analysis. How Rhea-AI works. Not financial advice.